JNJ logo

JNJ (JNJ)

Market Closed
12 Jun, 20:00
TSX TSX
CA$
30. 85
+0.19
+0.6197%
CA$
745B Market Cap
29.06 P/E Ratio
0.69% Div Yield
5,266 Volume
9.91 Eps
CA$ 30.66
Previous Close
Add Transaction
Day Range
30.6 30.9
Year Range
19.58 32.14
Want to track JNJ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

JNJ closed today higher at CA$30.85, an increase of 0.6197% from yesterday's close, completing a monthly increase of 6.8954% or CA$1.99. Over the past 12 months, JNJ stock gained 15.8468%.
JNJ pays dividends to its shareholders, with the most recent payment made on Jun 02, 2026.
The stock of the company had never split.
The company's stock is traded on one exchange.

JNJ Chart

JNJ (JNJ) FAQ

What is the stock price today?

The current price is CA$30.85.

On which exchange is it traded?

JNJ is listed on TSX.

What is its stock symbol?

The ticker symbol is JNJ.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.69%.

What is its market cap?

As of today, the market cap is 745B.

Has JNJ ever had a stock split?

No, there has never been a stock split.

JNJ Profile

Media Industry
Communication Services Sector
Mr. Joaquin Duato CEO
TSX Exchange
- ISIN
BR Country
138,200 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Johnson & Johnson, a renowned entity in the healthcare sector, operates globally with a broad focus on research, development, manufacturing, and sales of healthcare products. The company is structured in multiple segments, primarily Innovative Medicine and MedTech, catering to a vast array of therapeutic areas and medical needs. Founded in 1886, the company is headquartered in New Brunswick, New Jersey, illustrating a longstanding presence and commitment to healthcare innovation and advancement. Through its extensive product line and diversified service offerings, Johnson & Johnson reaches a wide audience, including retailers, wholesalers, distributors, hospitals, and healthcare professionals, providing prescription and non-prescription products alike.

Products and Services

The company's portfolio is divided into two main segments, each encompassing a variety of products and services designed to meet the complex demands of modern healthcare:

  • Innovative Medicine:

    This segment includes a range of products for different therapeutic areas. These encompass immunology (covering diseases like rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis), infectious diseases (including HIV/AIDS treatment), neuroscience (targeting mood disorders, neurodegenerative disorders, schizophrenia), oncology (focused on cancers such as prostate, lung, bladder, and hematologic malignancies), cardiovascular and metabolism (addressing conditions like thrombosis, diabetes, and macular degeneration), and pulmonary hypertension, specifically pulmonary arterial hypertension.

  • MedTech:

    This segment offers products and technologies across a range of medical fields. Interventional Solutions include electrophysiology products for heart rhythm disorders and technologies for severe coronary artery disease treatment. The neurovascular care line focuses on treating hemorrhagic and ischemic strokes. Orthopaedics products support treatments for hips, knees, trauma, spine, and sports injuries. The surgery portfolio covers advanced and general surgery technologies and solutions for breast aesthetics and ear, nose, and throat procedures. Additionally, MedTech offers visual health products like ACUVUE Brand contact lenses and TECNIS intraocular lenses for cataract surgery.

Contact Information

Address: One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933
Phone: 732 524 0400